Stealth BioTherapeutics Inc.
Stealth BioTherapeutics Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial in Patients With Barth Syndrome- 4TAZPower | Abnormalities, Multiple, Barth syndrome, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, X-linked disease, cardiovascular disorder, congenital heart disease, heart disorder, hereditary disease, inborn errors of metabolism, metabolic disease | Recruiting | Phase 4 | 2026-09-17 | NCT07531251 | |
| ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 3 | 2026-09-17 | NCT06373731 | |
| Study of Healthy Aging and Physical Function With Elamipretide | Aging, Healthy | Recruiting | Phase 2 | 2025-12-10 | NCT07275424 |